Replies to post #9413 on Guided Therapeutics Inc (GTHP)

[otced]

GTHP as we speak is already making money in International markets. International markets do not care as long as it say "Made in USA" Logo. Here is the good news with international markets first: Real time preparation for USA Mass markets, 2#: Adjustment and calibration of LuvivaSCAN for USfda APROVAL, #3, Creating supply chain and above all Acquiring free data for us FDA approval from Million of women's, basically paid Phase 3 Testing as we speak. No reason for R/S. GTHP Competition is
EXACT Sciences Corporation NASDAQ: EXAS 76.50 USD +0.22 (0.29%)

[GetSeriousOK]

All of Gene's PR's have been shooting blanks since the FDA rejection in 2014. It's pretty obvious that there are never going to be significant sales in Turkey or India or Africa or anywhere else. It's all been hype. Especially about Turkey.

Gene has no funding and I believe these poorer countries don't WANT to diagnose cervical cancer because they don't want to pay for treatment. Women are not equal to men in those countries. Sad but true.

The only hope for the Luviva Scan is the USA and I just don't see GTHP ever pulling that off. Not Gene's fault. The FDA killed this company in 2014. It's a zombie now. Zombies can stagger along for years and that's what GTHP is doing.